Gait-related disturbances adversely affect the quality of life of patients with Parkinson’s disease (PD), a condition affecting millions worldwide.
Eli Lilly to acquire Versanis in heated race for weight loss drugs
Eli Lilly said Friday it will acquire Versanis Bio, a private company developing an obesity drug that specifically targets fat mass, as the race among